DOC: HEPATITIS B NEWBORN PROPHYLAXIS PROTOCOLS


The following hepatitis B newborn prophylaxis protocols apply to: A.Infants born to HBsAg-positive mothers B. Infants born to unscreened mothers C.Infants born to families with a household member known to be HBsAg-positive NOTE: As follow-up of the newborn is determined by the parent/guardian’s area of residence, which may be in a First Nations Inuit Health jurisdiction, references to Public Health or instructions for Regional Public Health include First Nations Inuit Health.... Document/File: .pdf, filesize: n/a. Filetype: pdf. Filename: hepatitis-b-newborn-prophylaxis-protocols. Title: Hepatitis B Newborn Prophylaxis Protocols. 2014.

 

File Info:

  • Filesize: N/A
  • Source: gov_dot_mb_dot_ca
  •   Date Archived: 2017-05-27
  •   Author: N/A
 
 
 
 
 

Related Files:

 

  HEPATITIS B IMMUNE GLOBULIN

... PREVENTS HEPATITIS B INFECTION INPATIENTS WHO ARE KNOWN TO HAVE BEEN EXPOSED, INCLUDING NEONATES BORN TO HBSAG-POSITIVE WOMEN, BY PROVIDING PASSIVE IMMUNITY. ACTION AN IMMUNE GAMMA-GLOBULIN FRACTION CONTAINING HIGH TITERS OF ANTIBODIES TO THE HEPATITIS B SURFACE ANTIGEN. CONFERS PASSIVE IMMUNITY TO HEPATITIS B INFECTION. THERAPEUTIC EFFECTS: PREVENTION OF HEPATITIS B INFECTION. ...
  hepatitis-b-immune-globulin     PDF     2017-05-27  
 

 

  PHENYTOIN ADMINISTRATION IN THE NEWBORN AND INFANT

... TO EVALUATE THE EFÆCACY AND SAFETY OF PHENYTOIN (PHT) IN THE TREATMENT OF SITUATION-RELATED SEIZURES AND EPILEPSIES IN THE NEWBORN AND INFANT; THE CLINICAL HISTORIES OF 82 PATIENTS WERE RETROSPECTIVELY REVIEWED. SIXTY PATIENTS RECEIVED FOR STATUS EPILEPTICUS (SE), INTRAVENOUS PHT FOLLOWED BY LONG-TERM ORAL ADMINISTRATION FOR 27 OF THEM. ...
  phenytoin-administration-in-the-newborn-and-infant     PDF     2017-05-27  
 

 

  EPIDEMIOLOGY AND PREVENTION OF HEPATITIS B VIRUS INFECTION

... HEPATITIS B IS ONE OF THE MOST COMMON INFECTIOUS DISEASES GLOBALLY. IT HAS BEEN ESTIMATED THAT THERE ARE 350 MILLION CHRONIC HEPATITIS B VIRUS (HBV) CARRIERS WORLDWIDE. THE PREVALENCE OF CHRONIC HBV INFECTION VARIES GEOGRAPHICALLY, FROM HIGH (>8%), INTERMEDIATE (2-7%) TO LOW (<2%) PREVALENCE. ...
  epidemiology-and-prevention-of-hepatitis-b-virus-infection     PDF     2017-05-28  
 

 

  HEPATITIS B IMMUNE GLOBULIN (HUMAN)

... HEPATITIS B IMMUNE GLOBULIN (HUMAN) — HYPERHEPB® S/D TREATED WITH SOLVENT/DETERGENT IS A COLORLESS TO PALE YELLOW OR PINK STERILE SOLUTION OF HEPATITIS B HYPERIMMUNE IMMUNE GLOBULIN FOR INTRAMUSCULAR ADMINISTRATION; IT IS PRESERVATIVE-FREE AND LATEX-FRE ...
  hepatitis-b-immune-globulin-human     PDF     2017-05-27  
 

 

  HEPATITIS B VIRUS BIOLOGY

... HEPATITIS B VIRUS (HBV) CAUSES TRANSIENT AND CHRONIC INFECTIONS OF THE LIVER. TRANSIENT INFECTIONS MAY PRODUCE SERIOUS ILLNESS, AND APPROXIMATELY 0.5% TERMINATE WITH FATAL, FULMINANT HEPATITIS. CHRONIC INFECTIONS MAY ALSO HAVE SERIOUS CONSEQUENCES: NEARLY 25% TERMINATE IN UNTREATABLE LIVER CANCER (10). WORLDWIDE DEATHS FROM LIVER CANCER CAUSED BY HBV INFECTION PROBABLY EXCEED ONE MILLION PER YEAR (52, 162). ...
  hepatitis-b-virus-biology     PDF     2017-05-28  
 

 

  HEPATITIS B VIRUS: EPIDEMIOLOGY AND TRANSMISSION RISKS

... HEPATITIS B VIRUS (HBV) INFECTION IS A SERIOUS AND COMMON INFECTIOUS DISEASE OF THE LIVER, AFFECTING MILLIONS OF PEOPLE THROUGHOUT THE WORLD. THE INCUBATION PERIOD FOR HBV IS 45-180 DAYS, MOST COMMONLY 60-90 DAYS. ...
  hepatitis-b-virus-epidemiology-and-transmission-risks     PDF     2017-05-28  
 

 

  HEPATITIS B VIRUS REPLICATION AND INTEGRATION

... CHRONIC INFECTION WITH HEPATITIS B VIRUS (HBV) AFFECTS 240 MILLION PEOPLE WORLDWIDE AND MAY CAUSE LIVER DISEASE INCLUDING HEPATOCELLULAR CARCINOMA (HCC). INITIALLY PATIENTS HAVE HIGH LEVELS OF HBV DNA IN THEIR BLOOD, NO LIVER DISEASE AND EXPRESS THE E ANTIGEN (HBEAG). ...
  hepatitis-b-virus-replication-and-integration     PDF     2017-05-28  
 

 

  DACLATASVIR FOR TREATING CHRONIC HEPATITIS C

... DACLATASVIR IS RECOMMENDED AS AN OPTION FOR TREATING CHRONIC HEPATITIS C IN ADULTS, AS SPECIFIED IN TABLE 1, ONLY IF THE COMPAN Y PROVIDES DACLATASVIR AT THE SAME PRICE OR LOWER THAN THAT AGREED WITH THE COMMERCIAL MEDICINES UNIT. ...
  daclatasvir-for-treating-chronic-hepatitis-c     PDF     2017-05-27  
 

 

  CLINICAL GUIDELINES ON THE MANAGEMENT OF HEPATITIS C

... PATIENTS INFECTED WITH HEPATITIS C VIRUS (HCV) SHOULD BE REFERRED TO A CLINICIAN WITH A PARTICULAR INTEREST IN THE INFECTION. PATIENTS MUST HAVE ACCESS TO ADEQUATE COUNSELLING FROM A HEALTH CARER WITH KNOWLEDGE AND EXPERIENCE OF CHRONIC HCV INFECTION. ALL PATIENTS MUST HAVE ACCESS TO THE APPROPRIATE DIAGNOSTIC AND THERAPEUTIC OPTIONS AVAILABLE IN THE MANAGEMENT OF HCV INFECTION. ...
  clinical-guidelines-on-the-management-of-hepatitis-c     PDF     2017-05-27  
 

 

  TREATMENT OF TUBERCULOSIS IN PREGNANT WOMEN AND NEWBORN INFANTS

... MATERNAL TB HAS BEEN ASSOCIATED WITH AN INCREASED RISK OF SPONTANEOUS ABORTION, PERINATAL MORTALITY, SMALL SIZE FOR GESTATIONAL AGE, AND LOW BIRTH WEIGHT. THE OUTCOME IS UNFAVOURABLY INFLUENCED BY DELAYS IN DIAGNOSIS OR TREATMENT, ALONG WITH DISEASE OTHER THAN IN LYMPH NODES. ...
  treatment-of-tuberculosis-in-pregnant-women-and-newborn-infants     PDF     2017-05-27